BiT

/WETH

BioT is an ERC-20 utility token on Ethereum that revolutionizes biotechnology funding by providing a decentralized, transparent, and borderless platform connecting researchers, startups, investors, and enthusiasts worldwide. Traditional biotech funding suffers from centralized control, high intermediary fees of 10-20%, opaque processes, bureaucratic delays, and limited access for early-stage innovators and those in underserved regions. BioT solves this through audited smart contracts that enable direct milestone-based funding, where contributors send tokens to project wallets and funds are automatically locked until verifiable on-chain milestones are achieved, ensuring accountability and trust. All transactions are publicly viewable on Etherscan at contract address 0x7bC82B0775Bd344b1aC048b258b2d371Db5727a5, while seamless trading occurs on Uniswap V2 (liquidity pool: 0x07D322eFA22207F77aA0b8C6aEBf2A87035e0EE0) with strong ETH pairing. Key features include global wallet accessibility (e.g., MetaMask), upcoming staking and community governance for Q1 2026, Layer-2 integration (Optimism) in Q2 2026 for lower fees, and planned APIs for broader biotech platform integration. With a fixed total supply of 485,000,000 tokens and approximately 10 million circulating, BioT’s tokenomics allocate 50% to public sale and liquidity, 30% to locked development, 15% to vested team, and 5% to marketing and partnerships including a $2,000 airdrop. A 1% fee on funding transactions supports platform sustainability, with potential community-voted token burns for deflation. Already launched with initial liquidity and progressing through listings, pilots, and ecosystem growth, BioT empowers a community-driven ecosystem to accelerate breakthroughs in healthcare, agriculture, and sustainability. Join the mission at Uniswap V2 or contact [email protected] for partnerships.